MV
Insider selling
Michael Vincent Meluzio sold $32K of Cue Biopharma, Inc. (CUE) stock
Michael Vincent Meluzio, VP, Prin. Accounting Officer of Cue Biopharma, Inc. (CUE), sold 1,144 shares of CUE stock worth $32K, per an SEC Form 4 filed Oct 15, 2026.
It was an open-market sale.
The trade happened on Oct 12, 2026, 3 days before it was made public.
CUE has moved -24.4% since the trade date, from $24.61 to $18.60 (Oct 14, 2026 close).
- Traded
- Oct 12, 2026
- Disclosed
- Oct 15, 2026
- Filing delay
- 3 days
- Price since
- -24.4%
- Role
- VP, Prin. Accounting Officer
- Source
- SEC Form 4
More CUE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.